Tumor

News Tumor

  • Nano shake-up

    Significant advances have been made in chemotherapy over the past decade, but targeting drugs to cancer cells while avoiding healthy tissues continues to be a major challenge. Nanotechnology has unlocked new pathways for targeted drug delivery, including the use of nanocarriers, or capsules, that ca more

  • Catching the early spread of breast cancer

    When cancer spreads from one part of the body to another, it becomes even more deadly. It moves with stealth and can go undetected for months or years. But a new technology that uses "nano-flares" has the potential to catch these lurking, mobilized tumor cells early on. "We've taken perhaps the worl more

  • Weighing particles at the attogram scale

    MIT engineers have devised a way to measure the mass of particles with a resolution better than an attogram — one millionth of a trillionth of a gram. Weighing these tiny particles, including both synthetic nanoparticles and biological components of cells, could help researchers better understand th more

All news on tumor

White papers Tumor

  • Quantification of BRCA1 Expression Level Using Standard RT-PCR Reagents - a Sensitive Method for the Detection of Low Amounts of Transcripts

    Mutations in the breast cancer susceptibility gene, BRCA1, occur in the majority of families with multiple members affected with breast or ovarian cancer. Women who inherit a BRCA1 mutation have 40%-80% risk of developing breast cancer or ovarian cancer. However, up to 90% of breast cancers are sporadic, and mutations in BRCA1 seem to be a rare event in sporadic breast tumors. more

  • Genome Sequencer 20 System: Breakthrough in a New Applications Age of Sequencing

    The Genome Sequencer 20 System is an ultra-high-throughput automated DNA sequencing system capable of carrying out and monitoring sequencing reactions in a massively parallel fashion. Since the Genome Sequencer 20 System provides a complete solution for ultra-high-throughput DNA sequencing, an individual researcher can for the first time prepare samples and sequencing reactions, generate sequence reads, and assemble genome sequence data within days. more

  • Analysis of the DNA Methylation Patterns at the BRCA1 CpG Island

    Germ-line alterations of the BRCA1 gene confer a lifetime risk of 40% for ovarian cancers and of 40%-80% for ­breast cancers. It is likely that BRCA1 acts as a tumor suppressor gene. BRCA1 involvement in breast cancers does not seem to be restricted to familial cancers. Despite the absence of somatic mutations in the breast tissues, a down regulation of BRCA1 expression is associated with malignancy in human sporadic breast cancers. more

All white papers on tumor

Websites Tumor

Home - Enzo Life Sciences

© 2009 Enzo Life Sciences, Inc. -- choose -- Alexis Biomol Enzo Assay Designs Advanced Search New Website Highlights 100s of NEW Oxidative Stress Products We now offer a complete range of kits and reagents for oxidative stress research. 200 new Immunoassay Kits Enzo Life Sciences now offers a comple more

ibt - immunological and biochemical testsystems GmbH: IBT Systems

no items in cart Search: ibt systems Reutlingen, Germany You are here: ibtsystems.de ibt – immunological and biochemical testsystems GmbH: innovative tools for functional proteomics are our target! About us News Products Services Contact Application Notes and Working Instructions Terms and Condition more

MammaPrint | Personalize Your Breast Cancer Treatment | Agendia

Client Login :: News :: Events :: Investor Relations :: Careers :: Publications :: Ordering Home :: Site Map :: Contact Us   Patients About MammaPrint Questions & Answers FDA Clearance Getting Your MammaPrint MammaPrint Providers Insurance Coverage Questions & Answers Clinical Trials MINDACT MP-90 P more

All websites on tumor
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE